By Dave Sebastian

Thermo Fisher Scientific Inc. said its profit for the fiscal first quarter rose as revenue in its life-sciences solutions segment more than doubled.

The Waltham, Mass.-based maker of scientific and medical equipment on Thursday posted net income of $2.34 billion, compared with $788 million in the year-ago period. Earnings were $5.88 a share, compared with $1.97 a share in the same period last year.

Adjusted earnings were $7.21 a share. Analysts polled by FactSet were expecting $6.67 a share.

For the quarter ended April 3, revenue rose 59% to $9.91 billion from $6.23 billion. Analysts were looking for $9.72 billion.

Life-sciences solutions revenue rose to $4.2 billion from $1.77 billion. Analytical-instruments revenue rose to $1.39 billion from $1.1 billion. Specialty-diagnostics revenue rose to $1.62 billion from $958 million. Laboratory products and services revenue rose to $3.6 billion from $2.73 billion.

The company said it will provide updates to its 2021 guidance on its earnings call at 8:30 Eastern Time.

Write to Dave Sebastian at dave.sebastian@wsj.com

(END) Dow Jones Newswires

04-29-21 0629ET